P2RY12 and peripheral arterial disease: Rivaroxaban with aspirin groups were significantly associated with decreased risk of MALE, ALI, and the composite of MACE or MALE, and an increase risk of ITSH major bleeding in PAD patients regardless P2Y12 inhibitor use.